![Tuija Päivi Keinonen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tuija Päivi Keinonen
Président chez
TILT Biotherapeutics Oy
Profil
Tuija Päivi Keinonen is currently the Chairman & Chief Regulatory Officer at TILT Biotherapeutics Oy.
Previously, she served as the Chief Executive Officer at Medfiles Oy Ltd. from 1999 to 2020.
She also held the position of Managing Director at Medikalla Oy.
Additionally, she worked as a Director at Osuuskunta KPY from 2013 to 2017.
Postes actifs de Tuija Päivi Keinonen
| Sociétés | Poste | Début |
|---|---|---|
TILT Biotherapeutics Oy
 TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology Develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment | Président | - |
Anciens postes connus de Tuija Päivi Keinonen
| Sociétés | Poste | Fin |
|---|---|---|
Medfiles Oy Ltd.
 Medfiles Oy Ltd. BiotechnologyHealth Technology Provides contract research and analytical laboratory services | Directeur Général | 01/05/2020 |
| KPY OSK | Directeur/Membre du Conseil | 03/05/2017 |
Medikalla Oy
 Medikalla Oy Pharmaceuticals: MajorHealth Technology Provides contract research and drug development services | President | 13/05/2009 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Medikalla Oy
Medikalla Oy Pharmaceuticals: MajorHealth Technology Provides contract research and drug development services | Health Technology |
Medfiles Oy Ltd.
Medfiles Oy Ltd. BiotechnologyHealth Technology Provides contract research and analytical laboratory services | Health Technology |
Osuuskunta KPY
 Osuuskunta KPY Financial ConglomeratesFinance Provides investment services | Finance |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology Develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment | Health Technology |
